Reserve Inotropes for Select Cases of Acute or End-Stage Heart Failure

Do the IV inotropes dobutamine and milrinone still have a role in treating heart failure with reduced ejection fraction (HFrEF)?

Yes...but only in a small subset of patients.

Both meds increase arrhythmias. And widespread use fell out of favor years ago...due to concerns about increased mortality, especially in patients withOUT low cardiac output and hypotension.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals